Table 1. Baseline characteristics.
Patient characteristics |
Primary vaccination series N = 243 n(%) |
Additional primary shot N = 112 n(%) |
---|---|---|
Age, years, median (IQR) | 67 (59–75) | 67 (59–75) |
Male | 127 (52) | 59 (53) |
Race Asian Black or African American Hispanic or Latino White Other Missing |
4 (2) 11 (4) 23 (10) 189 (78) 11 (4) 5 (2) |
0 3 (3) 6 (5) 98 (88) 3 (3) 2 (2) |
Disease type Burkitt’s, DLBCL, PMBL CLL/SLL Hodgkin’s lymphomas (HL) Indolent lymphomas† Mantle cell lymphoma (MCL) T-cell lymphomas (TCL)‡ Other§ |
56 (23) 55 (22) 20 (8) 72 (30) 12 (5) 24 (10) 4 (2) |
24 (21) 24 (21) 9 (8) 36 (32) 8 (7) 8 (7) 3 (3) |
Comorbidities Cardiovascular disease¶ COPD Autoimmune disease†† Mild liver disease‡‡ Diabetes Chronic kidney disease HIV/AIDS Smoking history Current smoker Former smoker |
106 (44) 6 (3) 27 (11) 6 (3) 38 (16) 10 (4) 6 (3) 8 (3) 74 (30) |
49 (44) 3 (3) 13 (12) 2 (2) 19 (17) 7 (6) 2 (2) 4 (4) 33 (30) |
Vaccine received Pfizer-BioNTech Moderna Johnson&Johnson Unknown |
115 (47) 79 (33) 3 (1) 46 (19) |
66 (59) 41 (37) 0 5 (4) |
†Includes follicular lymphomas, marginal zone lymphoma, lymphoplasmacytic lymphoma, and Waldenstrom macroglobulinemia.
‡Includes peripheral T-cell lymphomas not otherwise specified (NOS), anaplastic large cell lymphoma (ALCL), cutaneous T-cell lymphomas, angioimmunoblastic T-cell lymphoma (AITL), and acute T-cell leukemia/lymphoma (ATLL).
§Include monoclonal gammopathy of undetermined significance (MGUS), T-cell prolymphocytic leukemia (T-PLL), Essential thrombocytosis, and primary CNS lymphoma.
¶Cardiovascular disease defined as coronary artery disease, hypertension, or cerebrovascular accident.
††Includes autoimmune diseases, rheumatological disorders, and connective tissue disease.
‡‡Mild liver disease defined as either chronic hepatitis or cirrhosis without portal hypertension.
DLBCL = diffuse large B-cell lymphoma; PMBL = primary mediastinal B-cell lymphoma; COPD = chronic obstructive pulmonary disease; HIV/AIDS = human immunodeficiency virus/acquired immunodeficiency syndrome.